Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1576-1581

  Kim, Kwang Nam ^a   Watanabe, Shohei ^a   Ma, Yuhe ^a   Thornton, Sherry ^a   Giannini, Edward H ^a   Hirsch, Raphael ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; DISEASE SEVERITY; GENE TRANSFER; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0034141551     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1576     Document Type: Article

References (40)

1. Koch, A. E., S. L. Kunkel, and R. M. Strieter. 1995. Cytokines in rheumatoid arthritis. J. Invest. Med. 43:28.
2. Brennan, F. M., R. N. Maini, and M. Feldmann. 1992. TNFα-a pivotal role in rheumatoid arthritis? Br. J. Rheumatol. 31:293.
3. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler. et al. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141.
4. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibilily complex expression. J. Exp. Med. 174:915.
5. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Gindizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
6. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
7. Katsikis, P. D., C. Q. Chu, F. M. Brennan, R. N. Maini, and M. Feldmann. 1994. Immunoregulatory role of iriterleukin-10 in rheumatoid arthritis. J. Exp. Med. 179:1517.
8. Kasama, T., R. M. Stricter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin Invest. 95: 2868.
9. Joosten, L. A. B., E. Lubberts, P. Durez, M. M. A. Helsen, M. J. M. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
10. Walmsley, M., P. D. Katsikis, E. Abney, S. Parry, R. O. Williams, R. N. Maini, and M. Feldmann. 1996. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39:495.
11. Cush, J. J., J. B. Splawski, R. Thomas, J. E. McFarlin, H. Schulze-Koops, L. S. Davis, K. Fujita, and P. E. Lipsky. 1995. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:96.
12. Moore, K. W., P. Vieira, D. F. Florentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230.
13. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207.
14. MacNeil, I. A., T. Suda, K. W. Moore, T. R. Mosmann, and A. Zlotnik. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145:4167.
15. Go, N. F., B. E. Castle, R. Barren, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625.
16. Ma, Y., S. Thornton, L. E. Duwel, G. P. Boivin, E. H. Giannini, J. M. Leiden, J. A. Bluestone, and R. Hirsch. 1998. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J. Immunol. 161:1516.
17. Apparailly, F., C. Verwaerde, C. Jacquet, C. Auriault, J. Sany, and C. Jorgensen. 1998. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160:5213.
18. Whalen, J. D., E. L. Lechman, C. A. Carlos, K. Weiss, I. Kovesdi, J. C. Glorioso, P. D. Robbins, and C. H. Evans. 1999. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. 162:3625.
19. Jorgensen, C., F. Apparailly, E. Canovas, C. Verwaerde, C. Auriault, C. Jacquet, and J. Sany. 1999. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum. 42:678.
20. Muller-Ladner, U., C. H. Evans, B. N. Franklin, C. R. Roberts, R. E. Gay, P. D. Robbins, and S. Gay. 1999. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum. 42:490.
21. Rolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91:215.
22. Graham, F., and A. Van Der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:446.
23. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59.
24. Klapper, J., B. Kotzin, L. Herron, E. Gelfand, R. Bigler, A. Boylston, S. Carrel, D. Posnett, Y. Choi, and P. Marrack. 1989. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 244:811.
25. Hughes, C., J. A. Wolos, E. H. Giannini, and R. Hirsch. 1994. Induction of T cell anergy in an experimental model of autoimmunity using non-mitogenic anti-CD3 monoclonal antibody. J. Immunol. 153:3319.
26. Thornton, S., L. E. Duwel, G. P. Boivin, Y. Ma, and R. Hirsch. 1999. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum. 42:1109.
27. Smith, T. A., M. G. Mehaffey, D. B. Kayda, J. M. Saunders, S. Yei, B. C. Trapnell, A. McClelland, and M. Kaleko. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5:397.
28. Worgali, S., P. L. Leopold, G. Wolff, B. Ferris, N. Van Roijen, and R. G. Crystal. 1997. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum. Gene Ther. 8:1675.
29. Ghivizzani, S. C., E. R. Lechman, R. Kang, C. Tio, J. Kolls, C. H. Evans, and P. D. Robbins. 1998. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor a soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA 95:4613.
30. Marinova, L., R. O. Willams, L. J. Mason, M. Feldmann, and R. N. Maini. 1995. Kinetics of pro-inflammatory cytokine expression in early collagen-induced arthritis (CIA). Arthritis Rheum. 38(Suppl.):S354.
31. Piguet, P. F., G. E. Gran, C. Vesin, H. Loetscher, R. Gentz, and W. Lesslauer. 1992. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis faclor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510.
32. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
33. Wooley, P. H., J. Dutcher, M. B. Widmer, and S. Gilds. 1993. Influence of a rccombinant human soluble tumor necrosis faclor receptor Fc fusion protein on type II collagen-induced arthritis in mice. J. Immunol. 151:6602.
34. Williams, R. O., J. Ghrayeb, M. Feldmann, and R. N. Maini. 1995. Successful therapy of collagen-induced arthritis with TNF-receptor-IgG fusion protein and combination with anti-CD4. Immunology 84:433.
35. Mori, L., S. Iselin, G. De Libero, and W. Lesslauer. 1996. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type I (TNFRI)-IgG1-treated and TNFR1-deficient mice. J. Immunol. 157:3178.
36. Le, C. H., A. G. Nicolson, A. Morales, and K. L. Sewell. 1997. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor a receptor gene. Arthritis Rheum. 40:1662.
37. Quattrocchi, E., M. Walmsley, K. Browne, R. O. Williams, L. Marinova-Mutafchieva, W. Buurman, D. M. Butler, and M. Feldmann. 1999. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. J. Immunol. 163:1000.
38. Marino, M. W., A. Dunn. D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093.
39. Cope, A. P., R. S. Liblau, X. D. Yang, M. Congia, C. Laudanna, R. D. Schreiber, L. Probert, G. Kollias, and H. O. McDevitt. 1997. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185:1573.
40. + T cells. J. Immunol. 159:591.